1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015" provides data on the Extrahepatic Bile Duct Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Extrahepatic Bile Duct Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Extrahepatic Bile Duct Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Extrahepatic Bile Duct Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Extrahepatic Bile Duct Cancer 19
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
AstraZeneca PLC 26
Clinical Trial Overview of AstraZeneca PLC 26
PrECOG, LLC. 27
Clinical Trial Overview of PrECOG, LLC. 27
Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Top Institutes / Government 29
National Cancer Institute 29
Clinical Trial Overview of National Cancer Institute 29
Memorial Sloan Kettering Cancer Center 31
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 31
Massachusetts General Hospital 32
Clinical Trial Overview of Massachusetts General Hospital 32
National Institutes of Health Clinical Center 33
Clinical Trial Overview of National Institutes of Health Clinical Center 33
North Central Cancer Treatment Group 34
Clinical Trial Overview of North Central Cancer Treatment Group 34
University of Chicago 35
Clinical Trial Overview of University of Chicago 35
Mayo Clinic 36
Clinical Trial Overview of Mayo Clinic 36
SWOG 37
Clinical Trial Overview of SWOG 37
Northwestern University 38
Clinical Trial Overview of Northwestern University 38
Samsung Medical Center 39
Clinical Trial Overview of Samsung Medical Center 39
Five Key Clinical Profiles 40
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 94

List of Tables
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 6
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 12
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 15
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 16
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Extrahepatic Bile Duct Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19
Extrahepatic Bile Duct Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 20
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 26
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PrECOG, LLC., 2015* 27
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 28
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 29
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 31
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 32
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2015* 33
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2015* 34
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 35
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 36
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 37
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 38
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 39

List of Figures
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 12
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 15
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 16
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.